Clinical Trial Data Review and Clinical Applications for Class III Antiarrhythmic Therapeutics for Patients with Atrial Fibrillation

Nov 28, 2023 | Arrhythmia

2) .@SeguraCardio is discussing "Clinical Trial Data Review & Clinical Applications for Class III #Antiarrhythmic Therapeutics for Pts with #AFib." Don't miss the previous installment on this topic (still available for🆓CE/#CME) at...

What Every Cardiologist Should Know About ATTR-CM

Nov 14, 2023 | ATTR

2) Follow this 🧵to earn 0.5hr CE/#CME. This program is intended for #healthcare providers. Statement of accreditation & faculty disclosures at https://t.co/gvXca4G9Xm. This program supported by an independent educational grant from AstraZeneca.#MedEd...

LATE-BREAKING DATA FROM AHA23: AZALEA-TIMI 71 SUPPORTS THE FACTOR XI HYPOTHESIS IN ATRIAL FIBRILLATION

Nov 12, 2023 | Antithrombotics

2) Yes, #ChristianRuffMD just left the podium and we have MUCH to discuss in this LIVE program from #AHA23. Our guest author is Sid Patel MD @SidPatelMD, #Cardiology & #CriticalCare @BrighamFellows @HarvardMed & Research Fellow @TIMIStudyGroup....

Improving Outcomes and Symptom Burden in Patients with Atrial Fibrillation and Rapid Ventricular Response: New Data from AHA23

Nov 11, 2023 | Arrhythmia

1b) That #EHRA affiliation is 🔑to today's program, as we focus on #AFib with rapid ventricular response #RVR. Atrial fibrillation with RVR leads to loss of atrial kick, shortened ventricular filling time, and increased #myocardial oxygen demand....

Update from AHA23: New Data on Optimizing Lipid-Lowering Management in Statin-Intolerant and Statin-Resistant Patients

Nov 8, 2023 | LIPIDS

2) This program is supported by an educational grant from Esperion Therapeutics & is intended for #HCPs. Statement of accreditation & faculty disclosures at https://t.co/gvXca4G9Xm. Earn .75hr 🆓CE/#CME by following this 🧵!@MedTweetorials— cardio-met...